<DOC>
	<DOCNO>NCT00665652</DOCNO>
	<brief_summary>The purpose study learn effect drug , lenalidomide ( Revlimid® ) , neuropathy ( damage nerve affect feeling strength ) associate Nonmalignant Monoclonal Gammopathy Undetermined Significance ( MGUS ) .</brief_summary>
	<brief_title>Study Lenalidomide Treatment Neuropathy Associated With Monoclonal Gammopathy Undetermined Significance</brief_title>
	<detailed_description>Screening : All subject eligible screen must sign informed consent study prior study related procedure . Study Design : This open-label , single-institutional clinical study lenalidomide treatment MGUS associate neuropathy . Eligible patient follow 28 day start study drug . Subjects remain eligible 28 day pretreatment period receive lenalidomide 25 mg per day day 1-21 follow 7 day rest ( 28-day cycle ) 12 cycle . All patient treatment follow included intention treat group . Patients evaluate every three month TNS . On-treatment patient must come clinic least monthly first 3 cycle , come per schedule study assessment stable dose lenalidomide least one cycle . Subjects enrol study 14 month . Lenalidomide administration : Lenalidomide oral medication take approximately time day without food . Lenalidomide capsule swallow whole , broken , chew open . If dose lenalidomide miss , take soon possible day . If missed entire day , make . Patients take prescribe dose lenalidomide instruct seek emergency medical care need contact study staff immediately . Dosing Regimen : The plan dose lenalidomide investigation 25 mg/day , orally day 1-21 follow 7 day rest ( 28 day cycle ) . Dosing morning approximately time day . The plan dose : Plavix 75mg/day aspirin 325mg/day . Subjects experience adverse event may need study treatment modification</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Monoclonal Gammopathy Undetermined Significance</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Clinically proven MGUS associate neuropathy Total Neuropathy Score ( TNS ) ≥5 ( determined exam , history confirmatory EDX test association MGUS ( IgM , IgG , IgA ) ) Disease duration less equal 8 year Able take Plavix 75mg/day aspirin 325 mg daily prophylactic anticoagulation . ( patient currently take warfarin stable INR may stay current dose ) Patients previously treat thalidomide Patients previously treat lenalidomide Any serious medical condition , laboratory abnormality , psychiatric illness would prevent subject signing informed consent form . The development erythema nodosum characterize desquamate rash take thalidomide similar drug Known positive HIV infectious hepatitis , type A , B C Medical history deep venous thrombosis hypercoagulable state Gastrointestinal abnormality include : inability take oral medication , requirement intravenous alimentation , prior surgical procedure affect absorption , active peptic ulcer disease Patients dementia , serious neurological disease , uncompensated medical illness , substance abuse debilitate psychiatric illness . A serious uncontrolled medical disorder active infection would impair patient 's ability receive study treatment . Significant cardiac disease , include uncontrolled high blood pressure , unstable angina , congestive heart failure , myocardial infarction within previous 6 month serious cardiac arrhythmia exclude . Medical condition associate neuropathy active thyroid disease , diabetes mellitus , lupus , nutritional deficiency , malignancy , human immunodeficiency virus infection , alcohol dependence , amyloidosis , connective tissue disease GuillainBarre Syndrome . Medications toxic exposure know cause neuropathy , family history neuropathy also ground exclusion . Pregnant breast feeding female . ( Lactating female must agree breast feed take lenalidomide ) . Subjects allergic aspirin Plavix ( clopidogrel )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Neuropathy</keyword>
	<keyword>Nonmalignant Monoclonal Gammopathy Undetermined Significance ( MGUS )</keyword>
	<keyword>MGUS</keyword>
</DOC>